Skip to content

Topics: Pharmacy

  • Representatives from STUNS, Testa Center, SciLifeLab, ALIS and Lunds University at a kick-off for the BRIDGE Sweden project, which is supported by SweLife through the Swedish Innovation Agency, Vinnova.

    BRIDGE Project aims to strengthen Swedish path from research to commercialization

    The Vinnova project BRIDGE Sweden is receiving a 7.7 million SEK investment to streamline the transition from research to commercialization of biological pharmaceuticals and precision medicine. The initiative aims to integrate research infrastructure with innovation systems, develop new cell lines on SciLifeLab's DDD platform, and enhance Sweden's global position in drug development.

  • Fredrik Almqvist and Marta Bally are the new Directors of UCMR. "An important part of our leadership is representing the diverse aspects of UCMR, a broad center with nearly 70 research leaders". Photo: Mattias Pettersson/Umeå University

    New UCMR Directors focus on BSL-3 labs and clinical ties

    Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments.